CN Patent

CN105164136B — 作为激酶抑制剂的大环化合物

Assigned to Merck Patent GmbH · Expires 2017-12-22 · 8y expired

What this patent protects

式I的化合物是GCN2的抑制剂并尤其可用于治疗癌症， 其中X、Y、Q 1 、M、Q 2 和B具有权利要求1中指示的含义。

USPTO Abstract

式I的化合物是GCN2的抑制剂并尤其可用于治疗癌症， 其中X、Y、Q 1 、M、Q 2 和B具有权利要求1中指示的含义。

Drugs covered by this patent

Patent Metadata

Patent number
CN105164136B
Jurisdiction
CN
Classification
—
Expires
2017-12-22
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.